Embolization, Inc.’s Polymer-Based NED Coil Evaluated in Limited-Market Release 

April 7, 2026—Embolization, Inc. announced findings from the limited-market release of the company’s nitinol enhanced device (NED), which is a radiopaque, polymer-based embolic coil.

In the initial cases conducted at four institutions, physicians used more than 70 NED coils. In all cases, the device showed consistent performance in venous and arterial applications across male and female patients, ages 21-80 years.

The NED embolic coil received FDA approval for arterial and venous embolization in peripheral vasculature in June 2025.

As noted in the press release, the NED devices use the company’s shape-memory biocompatible polymers and have demonstrated improved vascular occlusion while minimizing artifacts in MRI and CT imaging that occur with traditional metal devices.

Interventional radiologist Mark J. Garcia, MD, who has used the coils in procedures at EndoVascular Consultants in Wilmington, Delaware, commented in the company’s press release, “The Embolization device is very effective in what it does, successfully occluding vessels quickly.”

Dr. Garcia also noted the ability of the coils to pack tightly. “We are seeing much better pack density than the coils that are on the market,” he stated, and further explained it leads to the need for fewer coils in a case, and ultimately lower cost.